(Q41730065)

8 October 2017

1 reference

title

Prophylaxis for neonatal group B streptococcus infections (English)

1 reference

8 October 2017

Siegel JD

1

1 reference

8 October 2017

publication date

1 February 1998

1 reference

8 October 2017

published in

Seminars in Perinatology

1 reference

8 October 2017

volume

22

1 reference

8 October 2017

issue

1

1 reference

8 October 2017

page(s)

33-49

1 reference

Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Invasive group B streptococcal disease: the emergence of serotype V

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Identification of cpsD, a gene essential for type III capsule expression in group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Immunization to prevent group B streptococcal disease: victories and vexations

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Antibiotic resistance patterns of group B streptococci in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prosthetic hip-joint infection associated with a penicillin-tolerant group B streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Clinical perspectives on penicillin tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Anorectal and vaginal carriage of group B streptococci during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Vaginal Colonization with Group B Streptococcus: A Study in College Women

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Epidemiology of Group B Streptococcus: Longitudinal Observations during Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. II. Predictive Value of Prenatal Cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Significance of a positive urine group B streptococcal latex agglutination test in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. I. Epidemiologic Rationale

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Outbreak of early onset group B streptococcal sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Unusual occurrence of an epidemic of type Ib/c group B streptococcal sepsis in a neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Transmission of group B streptococci. Traced by use of multiple epidemiologic markers

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

A cluster of late onset group B streptococcal infections in low birth weight premature infants: no evidence for horizontal transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Genetic diversity of rRNA operons of unrelated Streptococcus agalactiae strains isolated from cerebrospinal fluid of neonates suffering from meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping)

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Typing of group B streptococci: comparison of pulsed-field gel electrophoresis and conventional electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention of excess neonatal morbidity associated with group B streptococci by vaginal chlorhexidine disinfection during labour. The Swedish Chlorhexidine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Randomized study of vaginal chlorhexidine disinfection during labor to prevent vertical transmission of group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Effect of cleansing the birth canal with antiseptic solution on maternal and newborn morbidity and mortality in Malawi: clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Antibiotic treatment of parturient women colonized with group B streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Penicillin at birth can help prevent early-onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention of group-B beta-haemolytic streptococcal septicaemia in low-birth-weight neonates by penicillin administered within two hours of birth

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Penicillin in Infants Weighing Two Kilograms or Less with Early-Onset Group B Streptococcal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Single-dose penicillin prophylaxis of neonatal group-B-streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention of early-onset group B streptococcal disease: another look at single-dose penicillin at birth

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Perinatal group B streptococcal colonization and infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention practices for perinatal group B streptococcal disease: a multi-state surveillance analysis. Neonatal Group B Streptococcal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Prevention of early-onset neonatal group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Impact of maternal group B streptococcal screening on pediatric management in full-term newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

Outcome of term gestation neonates whose mothers received intrapartum antibiotics for suspected chorioamnionitis

1 reference

https://api.crossref.org/works/10.1016%2FS0146-0005%2898%2980006-2

7 January 2021

10.1016/S0146-0005(98)80006-2

Identifiers

DOI

1 reference

8 October 2017

1 reference